Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
Pilot study of the feasibility of an innovative multimodal treatment combining intrapleural photodynamic therapy with videothoracoscopy followed by adjuvant immunotherapy with anti-PD-1 Nivolumab antibodies in patients with malignant pleural mesothelioma
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
20 participants in 1 patient group
Loading...
Central trial contact
Arnaud Scherpereel, MD,PhD; Eric Wasielewski, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal